Clinical Trial

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

Study acronym: APTTO-EXT
Recruiting
View on ClinicalTrials.gov →
Summary
Prolonged activated partial thromboplastin time (APTT) is a frequent laboratory finding that may reflect a broad spectrum of underlying conditions, ranging from benign laboratory abnormalities to clinically relevant hemostatic disorders. Clot waveform analysis (CWA), automatically generated during routine APTT testing by optical coagulation analyzers, provides additional quantitative and qualitative information on clot formation dynamics. The APTTO model is a previously developed two-step predictive algorithm based on CWA features designed to estimate the probability of a pathological cause of prolonged APTT and to differentiate lupus anticoagulant from intrinsic pathway factor deficiency or von Willebrand disease. Internal validation has demonstrated good discrimination and calibration. This multicenter observational study aims to perform an external validation of the APTTO model in independent patient cohorts, assessing its discrimination, calibration, and decision-analytic performance without model updating.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-02-10; most recent amendment 2026-04-27.
Status change: Not Yet Recruiting → Recruiting 2026-02-18
Trial Details
NCT Number NCT07418099
Lead Sponsor Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Conditions Coagulation Disorder, Blood, Prolonged APTT
Enrollment 1,500 participants
Start Date 2026-01-13
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-13